Bas Peters

Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

Benjamin F. Voight, Gina M. Peloso, Marju Orho‐Melander et al. · The Lancet · 2012 · 118 citations · Full text

Real-world outcomes versus clinical trial results of immunotherapy in stage IV non-small cell lung cancer (NSCLC) in the Netherlands

Christine M. Cramer‐van der Welle, Marjon V. Verschueren, Merel Tonn et al. · Scientific Reports · 2021 · 103 citations · Full text

Systematic evaluation of the efficacy–effectiveness gap of systemic treatments in metastatic nonsmall cell lung cancer

Christine M. Cramer‐van der Welle, Bas Peters, Franz M.N.H. Schramel et al. · European Respiratory Journal · 2018 · 62 citations · Full text

Pharmacogenetic Interactions Between <i>ABCB1</i> and <i>SLCO1B1</i> Tagging SNPs and the Effectiveness of Statins in the Prevention of Myocardial Infarction

Bas Peters, Andréi S. Rodin, Olaf H. Klungel et al. · Pharmacogenomics · 2010 · 46 citations

Genetic variability within the cholesterol lowering pathway and the effectiveness of statins in reducing the risk of MI

Bas Peters, Helmi Pett, Olaf H. Klungel et al. · Atherosclerosis · 2011 · 43 citations

Metabolic Syndrome, Epidemiology, Cardiovascular Disease +11